Jim Simons Tyra Biosciences, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 54,400 shares of TYRA stock, worth $869,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,400

Holding current value

$869,856

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.61 - $20.0 $631,584 - $1.09 Million	54,400 New	54,400 $892,000
Q2 2022 Aug 12, 2022	SELL	$5.26 - $11.19 $154,118 - $327,867	-29,300 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$10.03 - $14.09 $618,851 - $869,353	-61,700 Reduced 67.8%	29,300 $314,000
Q4 2021 Feb 11, 2022	BUY	$12.23 - $31.35 $1.11 Million - $2.85 Million	91,000 New	91,000 $1.28 Million

Others Institutions Holding TYRA

# of Institutions

Shares Held

32.4M

Call Options Held

600

Put Options Held

3.7K

View Full List

About Tyra Biosciences, Inc.

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $671M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

More about TYRA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account